Regulation of Na/H exchanger activity in glial tumor cells

L. A. McLean, N. K. Jorgensen, Peter M Cala

Research output: Contribution to journalArticle

Abstract

Glial tumor cells maintain a more alkaline intracellular pH (pHi) compared to non-transformed glial cells, despite increased H+ production. This increased pHi must therefore reflect differences in pH regulatory mechanisms between the tumor and normal glial cells, which may be exploited in order to control tumor growth. The steady-state pHi (in HCO3-free media) of the tumor cells ranged from 7.3 to 7.5, significantly (p<0.001) higher than that of the control astrocytes (pHi=7.0). A key pH regulatory mechanism is the Na/H exchanger (NHE), particularly in acidic medium when HCO3 is low. NHE activity following intracellular acidification (using NH4 prepulse) showed that maximum H+ flux during recovery was a linear function of 1/pHi. At any given pHi, the flux rate for the tumor cells was at least twice that for the control cells. Recovery from the acid load was dependent on extracellular Na and could be dose-dependently blocked by Amiloride and HOE694, inhibitors of the NHE. Calyculin A, a phosphatase inhibitor, caused a marked increase in pHi, which could be inhibited by Amiloride and HOE694. Calyculin also appeared to in duce altered phosphorylation of the exchanger, detected as a shift of protein banding on Western Blots. In addition to its role in pH regulation, the NHE is also involved in volume regulation in glial cells. Hyperosmotic cell shrinkage resulted in NHE activation, indicated by an increased pHi, which could be inhibited by Amiloride and HOE694. Based on these data, we propose that the glial tumor cells exhibit a higher pHi set point due to differences in isoforms of the NHE or modifications of the NHE regulatory pathway, such as different states of phosphorylation.

Original languageEnglish (US)
JournalFASEB Journal
Volume11
Issue number3
StatePublished - 1997

Fingerprint

Sodium-Hydrogen Antiporter
neuroglia
Glioma
Tumors
Cells
Amiloride
Phosphorylation
Neuroglia
phosphorylation
Fluxes
Recovery
Neoplasms
neoplasms
Acidification
astrocytes
neoplasm cells
sodium-hydrogen antiporter
shrinkage
Phosphoric Monoester Hydrolases
Astrocytes

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Regulation of Na/H exchanger activity in glial tumor cells. / McLean, L. A.; Jorgensen, N. K.; Cala, Peter M.

In: FASEB Journal, Vol. 11, No. 3, 1997.

Research output: Contribution to journalArticle

McLean, L. A. ; Jorgensen, N. K. ; Cala, Peter M. / Regulation of Na/H exchanger activity in glial tumor cells. In: FASEB Journal. 1997 ; Vol. 11, No. 3.
@article{2ff2e47fa7ec49ebba6de44d02d81c2a,
title = "Regulation of Na/H exchanger activity in glial tumor cells",
abstract = "Glial tumor cells maintain a more alkaline intracellular pH (pHi) compared to non-transformed glial cells, despite increased H+ production. This increased pHi must therefore reflect differences in pH regulatory mechanisms between the tumor and normal glial cells, which may be exploited in order to control tumor growth. The steady-state pHi (in HCO3-free media) of the tumor cells ranged from 7.3 to 7.5, significantly (p<0.001) higher than that of the control astrocytes (pHi=7.0). A key pH regulatory mechanism is the Na/H exchanger (NHE), particularly in acidic medium when HCO3 is low. NHE activity following intracellular acidification (using NH4 prepulse) showed that maximum H+ flux during recovery was a linear function of 1/pHi. At any given pHi, the flux rate for the tumor cells was at least twice that for the control cells. Recovery from the acid load was dependent on extracellular Na and could be dose-dependently blocked by Amiloride and HOE694, inhibitors of the NHE. Calyculin A, a phosphatase inhibitor, caused a marked increase in pHi, which could be inhibited by Amiloride and HOE694. Calyculin also appeared to in duce altered phosphorylation of the exchanger, detected as a shift of protein banding on Western Blots. In addition to its role in pH regulation, the NHE is also involved in volume regulation in glial cells. Hyperosmotic cell shrinkage resulted in NHE activation, indicated by an increased pHi, which could be inhibited by Amiloride and HOE694. Based on these data, we propose that the glial tumor cells exhibit a higher pHi set point due to differences in isoforms of the NHE or modifications of the NHE regulatory pathway, such as different states of phosphorylation.",
author = "McLean, {L. A.} and Jorgensen, {N. K.} and Cala, {Peter M}",
year = "1997",
language = "English (US)",
volume = "11",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Regulation of Na/H exchanger activity in glial tumor cells

AU - McLean, L. A.

AU - Jorgensen, N. K.

AU - Cala, Peter M

PY - 1997

Y1 - 1997

N2 - Glial tumor cells maintain a more alkaline intracellular pH (pHi) compared to non-transformed glial cells, despite increased H+ production. This increased pHi must therefore reflect differences in pH regulatory mechanisms between the tumor and normal glial cells, which may be exploited in order to control tumor growth. The steady-state pHi (in HCO3-free media) of the tumor cells ranged from 7.3 to 7.5, significantly (p<0.001) higher than that of the control astrocytes (pHi=7.0). A key pH regulatory mechanism is the Na/H exchanger (NHE), particularly in acidic medium when HCO3 is low. NHE activity following intracellular acidification (using NH4 prepulse) showed that maximum H+ flux during recovery was a linear function of 1/pHi. At any given pHi, the flux rate for the tumor cells was at least twice that for the control cells. Recovery from the acid load was dependent on extracellular Na and could be dose-dependently blocked by Amiloride and HOE694, inhibitors of the NHE. Calyculin A, a phosphatase inhibitor, caused a marked increase in pHi, which could be inhibited by Amiloride and HOE694. Calyculin also appeared to in duce altered phosphorylation of the exchanger, detected as a shift of protein banding on Western Blots. In addition to its role in pH regulation, the NHE is also involved in volume regulation in glial cells. Hyperosmotic cell shrinkage resulted in NHE activation, indicated by an increased pHi, which could be inhibited by Amiloride and HOE694. Based on these data, we propose that the glial tumor cells exhibit a higher pHi set point due to differences in isoforms of the NHE or modifications of the NHE regulatory pathway, such as different states of phosphorylation.

AB - Glial tumor cells maintain a more alkaline intracellular pH (pHi) compared to non-transformed glial cells, despite increased H+ production. This increased pHi must therefore reflect differences in pH regulatory mechanisms between the tumor and normal glial cells, which may be exploited in order to control tumor growth. The steady-state pHi (in HCO3-free media) of the tumor cells ranged from 7.3 to 7.5, significantly (p<0.001) higher than that of the control astrocytes (pHi=7.0). A key pH regulatory mechanism is the Na/H exchanger (NHE), particularly in acidic medium when HCO3 is low. NHE activity following intracellular acidification (using NH4 prepulse) showed that maximum H+ flux during recovery was a linear function of 1/pHi. At any given pHi, the flux rate for the tumor cells was at least twice that for the control cells. Recovery from the acid load was dependent on extracellular Na and could be dose-dependently blocked by Amiloride and HOE694, inhibitors of the NHE. Calyculin A, a phosphatase inhibitor, caused a marked increase in pHi, which could be inhibited by Amiloride and HOE694. Calyculin also appeared to in duce altered phosphorylation of the exchanger, detected as a shift of protein banding on Western Blots. In addition to its role in pH regulation, the NHE is also involved in volume regulation in glial cells. Hyperosmotic cell shrinkage resulted in NHE activation, indicated by an increased pHi, which could be inhibited by Amiloride and HOE694. Based on these data, we propose that the glial tumor cells exhibit a higher pHi set point due to differences in isoforms of the NHE or modifications of the NHE regulatory pathway, such as different states of phosphorylation.

UR - http://www.scopus.com/inward/record.url?scp=33750264994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750264994&partnerID=8YFLogxK

M3 - Article

VL - 11

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -